CA
CAN.AU Cann Group Ltd
- Market cap
- AUD 8.30M
- P/E
- 0.3x
- P/B
- 0.29x
- ROE
- 71.0%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is CAN.AU undervalued?
Graham numberThe Graham number of Cann Group Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cann Group Ltd fundamental analysis
9 of 22 checks passedROE 2/2
High return on equity (71.0%), above 20%.
ROA 1/1
Return on assets (39.0%) is above the industry median (-8.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (139.4%) is above the industry median (42.8%).
Revenue Growth 0/2
Revenue shrank 14.7% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (58.9%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is negative, against interest expense, below 5x.
PE vs Market 1/1
PE (0.3x) is below the market median (15.0x).
PE vs Industry 1/1
PE (0.3x) is below the industry median (21.9x).
PBV 1/1
Price to book (0.3x) is below the industry median (2.0x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 0.1, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Cann Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Full company profileCann Group Ltd financial statements
Cann Group Ltd annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 8.42K | 606K | 2.61M | 647K | 4.29M | 6.41M | 13.8M | 15.4M | 13.3M | 8.56M |
| Gross Profit | -116K | 501K | 2.14M | 6.22K | 4.25M | 11.2M | 20.6M | -21.8M | 5.15M | -8.06M |
| Operating Income | -2.19M | -5.62M | -12.4M | -16.6M | -23.5M | -29.1M | -37.3M | -27.5M | -8.94M | -12.0M |
| EBITDA | -2.46M | -3.87M | -9.51M | -13.9M | -22.6M | -24.4M | -24.6M | -35.5M | -8.94M | -6.16M |
| Net Income | -2.59M | -4.73M | -10.9M | -16.9M | -25.1M | -26.5M | -33.8M | -51.2M | -22.3M | 20.3M |
| EPS | -0.05 | -0.04 | -0.08 | -0.12 | -0.10 | -0.08 | -0.09 | -0.11 | -0.04 | 0.02 |
| Balance Sheet | ||||||||||
| Total Assets | 15.1M | 86.8M | 82.1M | 76.4M | 102M | 140M | 129M | 92.8M | 78.8M | 52.0M |
| Total Liabilities | 414K | 928K | 4.82M | 15.3M | 9.92M | 54.8M | 70.2M | 78.9M | 81.6M | 23.4M |
| Shareholders' Equity | 14.7M | 85.9M | 77.3M | 61.1M | 91.9M | 84.9M | 59.3M | 13.9M | -2.78M | 28.6M |
| Cash & Short-term Investments | 11.1M | 79.6M | 46.4M | 1.55M | 3.11M | 1.91M | 765K | 1.64M | 10.0K | 490K |
| Total Debt | 24.8K | 20.6K | 9.32M | 9.32M | 680K | 47.2M | 61.0M | 72.5M | 75.8M | 16.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -2.30M | -3.75M | -7.42M | -17.6M | -20.8M | -20.4M | -22.8M | -15.2M | -9.64M | -1.33M |
| Capital Expenditure | 329K | 5.60M | 25.4M | 34.4M | 16.3M | 45.2M | 3.10M | 2.51M | 157K | 406K |
| Free Cash Flow | -2.63M | -9.36M | -32.8M | -52.0M | -37.1M | -65.6M | -25.9M | -17.7M | -9.80M | -1.74M |
| Ratios | ||||||||||
| ROE | -17.7% | -5.5% | -14.1% | -27.7% | -27.3% | -31.2% | -57.0% | -368.1% | - | 71.0% |
| ROA | -17.2% | -5.4% | -13.3% | -22.2% | -24.7% | -19.0% | -26.1% | -55.2% | -28.4% | 39.0% |
| Net Profit Margin | -30,738.0% | -780.3% | -419.0% | -2,616.9% | -584.7% | -412.9% | -245.3% | -333.3% | -168.6% | 237.1% |
| Debt to Equity | 0.00x | 0.00x | 0.12x | 0.15x | 0.01x | 0.56x | 1.03x | 5.21x | - | 0.59x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cann Group Ltd dividends
Cann Group Ltd has not paid dividends in the last 10 fiscal years.
Who owns Cann Group Ltd
- Insiders 21.98%
- Institutions 3.60%
- Public & others 74.43%
- Shares outstanding 1.66B
- Free float 1.43B
Top funds holding CAN.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Global X Fds-The Global X Cannabis ETF | 8.11M | 2.92% | - | Feb 2021 |
Cann Group Ltd company profile
- Company name
- Cann Group Ltd
- Ticker
- CAN.AU
- ISIN
- AU000000CAN2
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- June
- Address
- 23 Greentek Court, Mildura, VIC, Australia, 3501
- Phone
- 61 3 9095 7088
- Website
- canngrouplimited.com
About Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Cann Group Ltd management
2- Mr. Michael Joseph RyanInterim Executive Chairman
- Mr. Steven Notaro BA, J.D.VP Compliance & Company Secretary